Connect with us

Hi, what are you looking for?

Alive Business PlanAlive Business Plan


Dukascopy Financial Performance Sees 80% Drop

Dukascopy Financial Performance Sees 80% Drop

Dukascopy, a company based in Switzerland, has recently released its interim consolidated statement of income for the first half of this year. The statement reveals a significant 80% decline in profits, amounting to CHF 889,000. This stands in stark contrast to the profits of CHF 3.9 million reported during the same period in the previous year.

Dukascopy is renowned for its global presence and specializes in retail foreign exchange, contracts for difference (CFD) brokerage, and retail banking activities across various jurisdictions. The company operates subsidiary branches in Japan, Switzerland, and Latvia, and also maintains a representative office in Hong Kong.

However, the latest financial report presents a different scenario. It highlights a notable decrease in trading income for Dukascopy during the first half of 2023, spanning the months leading up to June. Notably, the trading income figure is CHF 9.6 million, marking a 33% decline compared to the CHF 14.4 million recorded during the same period in the prior year.

In contrast, Dukascopy observed a significant increase in revenue from interest operations. This category encompasses interest-bearing assets such as loans, bonds, and money market funds. Impressively, this revenue surged by over 800%, rising from a modest CHF 76,000 to an impressive CHF 686 million. On the other hand, the revenue stream from commission-based businesses and services showed slight growth of 1%, reaching CHF 562.4 million—slightly up from CHF 554.6 million.

Despite this recent performance setback, Dukascopy effectively managed to control operating expenses. Impressively, the expenses figure saw a significant 74% reduction, decreasing from CHF 4.8 million in the first half of 2022 to CHF 1.2 million during the same period this year.

Profit Triumph Unveiled

This drop in profitability follows a remarkable performance in the previous year—2022—when Dukascopy experienced a profit surge of over 200%, culminating in a figure of CHF 6.4 million. This achievement solidified its position as the second-highest profit ever recorded in the company’s history.

Furthermore, the firm reported a commendable 21% increase in its operating income for 2022. The reported figure of CHF 27.4 million marked a clear rise from the CHF 22.7 million reported in the preceding year.

Dukascopy attributes this achievement to its adept management of a complex market landscape characterized by the Russia-Ukraine conflict, rising inflation, and increasing interest rates.

The post Dukascopy Financial Performance Sees 80% Drop appeared first on FinanceBrokerage.

Enter Your Information Below To Receive Latest News, And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Editor's Pick

    Overview The world of business technology has evolved. Driven by the shift towards distributed work and cloud application delivery, enterprise infrastructure is undergoing a...

    Latest News

    Donald Trump’s defense attorneys Wednesday asked the federal judge handling the government’s classified documents case to allow the former president and his legal team...


    Bitcoin Rebounds to $69,000 Quick Look Bitcoin rebounds to $69,000, influenced by optimistic FR statements and anticipation of the halving event. FR officials’ comments...


    0xDistro ICO (DISTRO) is Live. What does it offer? In the world of decentralized finance, 0xDistro emerges as a promising project. It presented itself...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024